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ABSTRACT  Cesium uptake by sodium-loaded frog sartorius muscles  was in- 
hibited 100 % by 10  --8 u ouabain and 10  -6 M  cymarin. The doses for 50 % inhibi- 
tion of cesium uptake  by five cardiotonie aglycones were  1.5  X  10-  7 M for 
strophanthidin, 2 X  10  -~ M  for telocinobufagin, 1.6 X  10-  e M  for digitoxigenin, 
2.4 X  10  -6 M  for periplogenin, and 6.3  X  10-  e M  for uzarigenin. Because of the 
limited solubility of sarmentogenin the maximum concentration studied was 
2  X  10  -6 M which inhibited cesium uptake about 36 %.  Inhibition of cesium 
uptake by cymarin was not reversed during a 3.5 hr incubation in fresh solution 
while the muscles treated with ouabain and strophanthidin recovered partly 
during this time. Cymarin was a  more potent inhibitor of sodium efflux than 
strophanthidin and periplogenin was less potent. Increased cesium ion concen- 
tration in the external solution decreased the strophanthidin inhibition of cesium 
uptake  but 25  mM  cesium did  not overcome the  inhibition  by  10-s-10  -6  M 
strophanthidin. Increased potassium ion concentration in the external solution 
decreased  but  did  not  completely overcome inhibition  of sodium  efltux by 
strophanthidin. It is concluded that potassium or cesium ions do not compete 
with these drugs for a  particular site on the ion transport complex. The same 
structural features of the drugs are necessary for inhibition of ion transport in 
frog muscle as are required for inhibition of ion transport in other tissues, inhibi- 
tion of sodium-potassium-stimulated ATPases, and toxicity to animals. 
INTRODUCTION 
Muscles enriched with sodium will take up cesium ions from the external solu- 
tion and extrude sodium ions (Beaugd and Sjodin, 1968). Although the mech- 
anism of this ion movement is unknown, both the cesium uptake and part of 
the sodium efflux are sensitive to the cardiotonic steroids such as ouabain and 
strophanthidin (Sjodin and Beaug6,  1967; Beaugd and Sjodin,  1968). As most 
studies of ion transport in frog muscle have used only high concentrations of 
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these drugs,  10  -5 M, tO inhibit the ion fluxes it is of interest to determine the 
effects of lower dosages of these drugs. Also, certain structural requirements 
for the drugs have been determined by measuring inhibition of ion transport 
by the drug in red blood cells and the lethal dosage in cats for a  variety of 
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these drugs (Kahn and Acheson, 1955; Kahn, 1957;  Glynn,  1957;  Machova, 
1961;  Chen,  1963;  Tamm,  1963).  Machova found a  direct relationship be- 
tween the mean lethal dosage in eats and the concentration required for 50% 
inhibition of potassium ion uptake in red blood cells. The ability of several 
active cardiac drugs to inhibit ion transport  in frog muscles is compared in 
this work. 
Several structural requirements found to be important for the activity of the 
drugs in other systems are (a) that the rings of the cyclopentanophenanthrene 
nucleus are joined A/B-cis,  B/C-trans, and C/D-c/s;  (b)  that there  is  a  hy- 
droxyl group/3 at C-14 and either a hydroxyl group or a glycosidic link/3 at 270  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  "  VOLUME  54  "  I969 
C-3; and (c) that the a, E-unsaturated five-membered lactone or a hexadienol- 
ide ring is joined/3 at C-17. Fig.  1 shows the basic, structure of the drugs with 
their numbering system. The cardiac drugs are shaped differently from the 
TABLE  I 
CARDENOLIDES TESTED*, 
joln~g d A/B 
Drug  R  C-19  rings§  SubltituentJ 
Sarmentogenin  .  H  CH3  5-/3  1  I-a-OH 
Periplogenin  H  CHs  5-/3  5-/3-OH 
Digitoxigenin  H  CH3  5-/3  -- 
Uzarigenin  H  CH3  5-t~  -- 
Strophanthidin  H  i CHO  5-/3  5-/3-OH 
Cymarin  D-Cymarosyl  CHO  5-/3  5-/3-OH 
Ouabain  L-Rhamnosyl  CH2OH :  5-/3  1  -/3-OH, 5-/3-OH, 
11 -a-OH 
* Adapted from Fieser and Fieser (1959). 
Refer to Fig. 3 for the location of the substituents. 
§ 5-/3, cis; 5.oL trans. 
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other common hormones such as the adrenal and sex hormones. In the cardiac 
drugs the ds fusion of  rings A/B and C/D gives the drugs a very bent configura- 
tion while the other hormones have all their rings fused trans  (Fig.  2).  The 
crystal structure of the simplest of the cardiac drugs, digitoxigenin, has just 
been determined and illustrates clearly this bent configuration of the molcule.1 
In the cardiac drugs the 3,fl-hydroxyl group and 1-/3 and 5-/3 groups are axial 
z Karle, I. L., andJ. Karle. 1969. The crystal structure of digitoxigenin, C~sHuO4 • Acta Cryst., Sect. B. 
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with respect to their rings. The five-membered lactone ring of the cardenol- 
ide is fi at C-17 and the plane of the lactone is almost perpendicular to that of 
the D ring of the steroid.  I The hexadienolide ring, a six-membered unsaturated 
lactone, is attached/3 to C-17 in the bufadienolides such  as  telocinobafagin. 
The cardenolides are more active as monosides of the C-3 hydroxyl group than 
are the free genins or oligosaccharides. The bufadienolides are more active as 
the  aglycones.  Several  other  molecular characteristics  have  been  found  to 
increase or decrease the activity ot the drugs but the pertinent ones will be 
mentioned while discussing the drugs used in this research. These drugs are 
listed in Table I  and Fig. 3. A similarity in the structural requirements of the 
drugs  for  inhibition of transport  in  different systems and  inhibition of the 
sodium-potassium-stimulated transport  adenosine triphosphatase  (ATPase) 
would indicate that these transport systems were similar (Skou,  1965). 
METHODS  AND  MATERIALS 
Preparation  of Muscles  Sartorius muscles from freshly killed frogs, Rana pipiens, 
were carefully dissected and mounted as described by Sjodin and Henderson (1964). 
Summer frog muscles  (April  to October) were enriched with sodium by storage for 
16-20 hr at 4-5°C in a potassium-free  Ringer solution.  Winter muscles were enriched 
similarly for 24 hr with only one muscle per 5 ml Ringer solution, then switched to 
fresh potassium-free Ringer solution and stored in the cold another 16-20 hr with two 
muscles per 5 ml. The potassium-free Ringer solution for winter muscles contained 5 
mg streptomycin per liter to reduce bacterial contamination. In the sodium effiux ex- 
periments high specific activity ~Na  (50-100  ~1 of a  1 mc/ml ~NaCI solution) was 
added to the muscles during the last 20 hr of cold storage. These methods were adapted 
from Carey and Conway (1954),  Sjodin  and  Henderson  (1964),  and Beaug6  and 
Sjodin (1968). As cesium uptake and sodium efflux depend on the internal concentra- 
tion of sodium, all muscles were enriched with sodium in order to have them in an 
approximately equal condition (Beaug6 and Sjodin,  1968; Sjodin and Beaug6,  1968). 
The dependence of the strophanthidin-sensitive sodium efttux on internal sodium con- 
centration is not so steep  for high sodium muscles  as it is for fresh or only slightly 
sodium-enriched muscles (Sjodin and Beaug6,  1968). 
Materials  The basic Ringer solutions are described in Table II. Strophanthidin 
and ouabain were purchased from Sigma Chemial Co. (St. Louis, Mo.) and cymarin 
and digitoxigenin were  purchased  from Boehringer Mannheim Corp. A crystalline 
preparation of strophanthidin was a gift of Dr. A. Hofman of Sandoz (Pharmaceutical 
Department, Sandoz Ltd., Basel, Switzerland). Dr. T. Reichstein kindly made a gift of 
periplogenin, sarmentogenin, and  strophanthidin (Institut ffir Organische Chemic, 
Universit/it  Basel,  Switzerland).  Dr.  K.  Meyer  made  a  gift  of  uzarigenin and 
telocinobufagin (Pharmazeutisches Institut der Universit~it, Basel, Switzerland). All 
drugs were prepared as 20 mM and 2 m~ solutions in ethanol and stored in the cold 
until used.  Uzarigenin and sarmentogenin were not completely soluble  at 20  mM. 
These solutions were allowed to settle and 50 #1 aliquots of the saturated solutions were 
used per 100 ml Ringer solution.  The concentrations of all the drugs, exceps telocino- 072  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  54  "  I969 
bufagin, were determined by their absorbance at 220 nm for solutions of 10--5-10  -6 M. 
The  molecular  extinction  coefficient, ~,  for  many  cardiac  glycosides and  genins  is 
similar, being about  1.6  X  104 for strophanthidin in water (Parsons,  1965; Dorfman, 
1953). 
Procedure for Cesium Uptake  The  procedure for measuring  cesium uptake with 
mCs as a  tracer was the same as described by Beaug6 and Sjodin (1968).  Cesium up- 
take was used rather than that of potassium or rubidium because cesium uptake is the 
most sensitive to the action of strophanthidin (Beauge and Sjodin, 1968). After control 
uptake  rates had  been established (2-2.5  hr),  the  muscles were  placed in  a  similar 
TABLE  II 
RINGER  SOLUTIONS* 
Concentration 
Tria-C1 
Solution  NaCI  KCI  CsCI  Sucrose  (85 %  neutral) 
mM  mM  mM  mM 
A  105  2.5  --  --  1 
B  105  7.5  --  --  1 
C  105  12  --  --  1 
D  8O  2.5  --  36  1 
E  105  --  2.5  --  1 
F  80  --  2.5  32.4  1 
G  80  --  5.0  28.8  1 
H  80  --  15  14.4  1 
I  80  --  25  --  1 
J  105  --  --  --  1 
K  ....  116 
L  80  --  --  36  I 
* pH adjusted to 7.2-7.3 with HC1.  All solutions contained 2 mu  CaC12. 
Ringer solution which contained the drug being tested. The rates of cesium uptake are 
linear for at least 20 hr in the absence of a drug (Beaug6 and Sjodin, 1968). The control 
solutions contained amounts of ethanol equal  to  those  in  the  drug  solution.  Except 
in  two  experiments with  10  ~  M drug,  the  most  ethanol used was 50/A  per I00 ml 
Ringer  solution,  about 8  n~.  This concentration  had  no effect on uptake.  Ethanol 
does inhibit a  brain sodium-potassium-stimulated  ATPase but only about  10-20 % 
at  100  mM  (Israel  and  Salazar,  1967).  Since the experiments with 10  -4 u  drug con- 
tained about 80 mu ethanol it is possible that the rates were inhibited 10 %  but con- 
trol muscles were  placed in  an  equal  amount  of  ethanol  so  that  the  comparative 
inhibition was due to the drug.  Inhibited uptake  was  followed for  2.5  hr.  The  es- 
timation of extracellular space  and  cation analysis followed the  methods of Beaug6 
and Sjodin (1968)  and Sjodin and  Henderson (1964).  In the experiments comparing 
the effects of increasing cesium concentration  on  strophanthidin  inhibition,  Ringer 
solutions F, G, H,  and  I  were  used, and the amount of isotope added to the uptake 
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Procedures  for Sodium Effiux  The method for sodium efflux has been described by 
Sjodin and Henderson (1964). For the first hour efflux for both muscles was followed 
into potassium-free Ringer solution  (J or  in  some  cases L);  then  one muscle was 
tested in a  potassium plus drug-Ringer solution and the control muscle in a  similar 
solution without drug. The cation analysis was by the same method used for cesium 
uptake.  Some experiments were done with cesium slution  (I)  instead  of potassium 
solution to stimulate the sodium efflux. 
RESULTS 
Inhibition of Cesium Uptake 
Fig.  4  shows  typical  data  from  an  experiment  in  solution  E  using  10  -e  M 
strophanthidin  to  inhibit  cesium uptake,  790-/0 in  this  case,  in  both muscles 
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FIGURE 4.  Uptake from 2.5 rn~ Cs Ringer solu- 
tion was  followed  for  2.5  hr.  Both muscles  were 
changed  to  a  similar  solution  containing  10  -6  M 
strophanthidin  and  uptake  measured  for  2.5  hr. 
The numbers in parentheses are  the uptake rates 
in micromoles per gram wet weight per hour. 
after 9.5 hr control  uptake.  Similar  experiments were done at other concen- 
trations in order to determine the dose-activity curve for strophanthidin  (Fig. 
5  a). Although there is a  slight increase in activity at  10  -1° M this is probably 
not significant as 10  -11 and  10  -12 M had no effect. The average internal sodium 
concentration  for the summer muscles was 93.3  ±  0.8 ~moles/g wet weight. 
Winter muscles revealed a slightly different sensitivity towards strophanthidin. 
When  the cold storage time was increased  to  about 40 hr  in potassium-free 
solution, the internal sodium concentration was raised and this resulted in the 
drug sensitivity being similar to that of summer muscles. Table III shows the 
average internal  sodium concentrations  from a  number of experiments.  The 
half-inhibition  of cesium  uptake  for  summer  muscles  or  very  high  sodium 
winter muscles occurred with  1.5-2  X  10  -7 M strophanthidin. 
A  comparison  of the  activity  of strophanthidin,  cymarin,  ouabain,  and 
sarmentogenin is shown in Fig. 5 b. Cymarin has a steroid structure similar to 
that of strophanthidin  except that it has a  D-cymarose in a  glycosidic link to 
the  3-~-hydroxyl  group.  In  ouabain  the  sugar  is  L-rhamnose  which  is  also 274  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  54  "  I969 
linked to the 3-~-hydroxyl group. Ouabain has  1-~- and 11-a-hydroxyl groups 
not found in cymarin. Also the C- 19 group is an alcohol rather than a  carbonyl. 
The testing of sarmentogenin to determine whether the  11-a-hydroxyl group 
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FmuRs 5 a. The points are average inhibitions of cesium uptake by strophanthidin.  The 
summer muscles were stored 16-20 hr in potassium-free Ringer solutions at 5°C while the 
winter muscles were similarly treated for about 40 hr. Uptake was measured from a 9.5 
ram cesium solution.  In this and other figures, bars represent  SE.  b. The muscles were 
stored 40 hr at 5°C in K-free Ringer solution. Each point is the average uptake by two mus- 
cles except 10  -~ M  strophanthidin  which is averaged from four muscles, c. Inhibition of  ce- 
sium uptake from 2.5 mM cesium Ringer solution was measured with winter muscles stored 
40 hr at 5°C in a K-free Ringer solution. Each point is the average of two muscles, d. A 
comparison  of the inhibition  of cesium uptake from 2.5 mM Cs Ringer solution by the 
ds-A/B configuration,  digitoxigenin,  and the trans-A/B form,  uzarigenin.  Each point is 
the average from two winter muscles stored 40 hr in K-free Ringer solution at 5°C. 
is the major reason for the increased activity of ouabain seems to indicate that 
it is not an important change. Sarmentogenin is also lacking the 5-fl-hydroxyl 
group and either an alcoholic or carbonyl group at C-19 which may account 
for its lower activity and solubility. 
Fig. 5 c  compares periplogenin and telocinobufagin. In these two drugs the A.  L.  AB~.t,  eS  Structure-Activity Relationships of Cardiotonic Steroids  275 
steroid is the same except that in telocinobufagin there is a  six-membered un- 
saturated  lactone  ring.  Telocinobufagin  is  15  to  20  times more  active  than 
periplogenin, with a  five-membered lactone, and about as active as strophan- 
TABLE  III 
INTERNAL  SODIUM  CONCENTRATIONS 
Hr  *  Muscles  Treatment  Na 
lamoles/g wet weight 
20  29~  Strophanthidln  23.3-I-0.8§ 
20  8  "  24.04-1.0 
40  12  "  33.84-1.5 
20  19  Cymarin  25.04-1.3 
40  6  "  38.44-1.8 
20  10  Periplogenin  22.94-1.4 
40  6  "  33.14-3.0 
20  18  Digitoxigenin  21.24-1.7 
40  6  "  36.54-4.4 
* The number of hours  the muscles were stored  in potassium-free Ringer 
solution at 5°C. 
~; These muscles were from summer frogs while the rest of the table is for 
winter muscles. 
§ The values are 4- sE. 
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FIGURE 6.  An illustration  of the difference  be- 
tween  the cis-  and  tram-junction  of the A and B 
rings of digitoxigenin and uzarigenin. 
thidin. The difference between the isomers,  digitoxigenin-uzarigenin,  is that 
the A/B rings are joined trans rather than cis in uzarigenin making the mole- 
cule more open than digitoxigenin (Fig. 6). This change results in a  slight loss 
in activity for uzarigenin  (Fig.  5  d).  Digitoxigenin,  periplogenin,  and uzari- 
genin are less active than strophanthidin. Periplogenin has only a  C-19 methyl 
group rather than a carbonyl group and is 10 times less active. Digitoxigenin is 
lacking both the 5-/3-hydroxyl group  and C-19 carbonyl group but is slightly 
more active than periplogenin. 276  TXE  JOURNAL  OF  OENERAL  PItYSIOLOOY  •  VOLUME  54  "  I969 
Recovery from Inhibition 
The reversibility of inhibition by cymarin, ouabain,  and strophanthidin was 
compared because cymarin and ouabain were more active than strophanthi- 
din. In the experiments summarized in Table IV control uptake was followed 
TABLE  IV 
REVERSIBILITY  OF  DRUG  INHIBITION 
The rates for each drug treatment averaged from four winter muscles stored 
40 hr at 5°C in K-free Ringer solution. The recovered rate is to be compared 
with the initial rate measured on the same muscle. All rates are q- sE. 
Drug  Recovered  rate 
10-~ M  Control rate  Inhibited  rate  after 3.5 hr 
iJ,  raole" g-t. hr-t 
Strophanthidin  1.154-0.14  0.1394-0.02  0.604-0.07 
Ouab  ain  1.03 4-0.06  0.104-0.02  0.29  4-0.09 
Cymarin  1.264-0.10  0.11 4-0.02  0.11 4-0.02 
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FmuR~ 7.  Cesium  uptake in the presence and absence of strophanthidin was measured 
in various cesium Ringer solutions. Uptake was measured for 2.5 hr for the control rates 
and inhibited rates. The summer muscles were stored 20 hr at 5°C in K-free Ringer solu- 
tion. The control points are averages of six muscles except for 15 m_M Cs which is from 
three muscles. The other points are averages of two muscles except 15 mM points which 
are from one muscle. 
for 2-2.5  hr,  inhibited uptake for another 2  hr,  and  recovery for 3.5  hr.  A 
longer recovery time, 5-8 hr, would have allowed the strophanthidin-treated 
muscles to recover completely (Beaug~ and Sjodin, 1968). In this comparison 
the  strophanthidin-treated muscles  recovered to  about  50%  of their  initial 
rates, ouabain-treated ones to 25o-/0 of their initial rates, and cymarin-treated 
ones not at all. Since cymarin and ouabain are about equally potent inhibitors 
of cesium uptake, their different behavior here might be due to the different 
sugars. A.  L.  A~p.ImS  Structure-Activiq Relationships of Cardiotonic Steroids  °77 
Effect of Raising  the External  Cesium Concentration 
A series of experiments measuring the inhibition of cesium uptake by strophan- 
thidin  at different external cesium concentrations  is shown in Fig.  7.  As the 
cesium concentration  was raised  there was some reduction  in the inhibition, 
but Table V  shows that the per cent inhibition with  10  -6 M was about 800-/o at 
all cesium concentrations.  Even at the lower drug concentrations  the inhibi- 
tion was not removed by 25 mM cesium. 
Inhibition  of Sodium Efftux 
The ability of the drugs to inhibit sodium efflux was compared using sodium- 
rich muscles labeled with ~2Na (Fig. 8). In this experiment efflux from a pair of 
TABLE  V 
PER  CENT  INHIBITION  OF  CESIUM 
UPTAKE  BY  STROPHANTHIDIN* 
Concentration  of strophanthidin  Per cent inhibition 
External  cesium  lO-0 M  10-7 M  10  -9 M 
mM 
2.5  82  40  0 (--I-9) t 
5.0  77  49  36 
15  82  58  37 
25  84  60  50 
* The data  are from Fig.  10. 
""8  1  :~ In this case 10  M stimulated ces'um uptake 9%. 
muscles into potassium-free Ringer solution  (J)  was followed for  1 hr.  Then 
efflux from one muscle was followed in 2.5 rnM potassium Ringer solution (A) 
and  compared with effiux from the other muscle into  a  similar  solution con- 
taining  10  -7 M strophanthidin.  In this case there was a  25% inhibition  of the 
potassium-stimulated efflux. A concentration of 10  -5 M strophanthidin  blocked 
all the potassium-stimulated sodium efflux. A dose-activity curve for strophan- 
thidin inhibition of sodium efflux was prepared. The curve in Fig. 9 was steeper 
than  that for cesium uptake,  going from  100% inhibition  at  10  -s M to 0% at 
10 -s M strophanthidin.  In order to use cesium to stimulate the sodium pump 
the cesium concentration  was raised to 25 rnM and consequently the external 
sodium concentration was lowered to 80 rnM for an osmotically balanced solu- 
tion. To insure that lowered sodium concentration did not affect the sensitivity, 
the  inhibition  produced  by strophanthidin  was measured  with  only  80  mM 
sodium outside (solutions L  and D). The per cent inhibitions were not signifi- 
candy different even though the absolute rates were somewhat higher  in the 
lower sodium solutions. ~7  8  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  54  "  z969 
The  data in  Table  VI  show  the  inhibition of sodium  efflux  by cymarin, 
strophanthidin,  and periplogenin when either solution A  (2.5 mM potassium) 
or solution I  (25 mM cesium)  was used to stimulate the pump. Also included 
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FIGURE 8.  Sodium efl]ux was 
measured  into  potassium-free 
Ringer  solution  for  1  hr  and 
then  into  2.5  mM  potassium 
Ringer  solution  for  another 
hour.  During  the  time  in 
potassium  solution  one  muscle 
was  also exposed  to  I0 -T  M 
strophanthidin.  There is a 95% 
inhibition  of  the  potassium- 
stimulated  sodium  emux.  The 
numbers in parentheses  are the 
rates  of  sodium  emux  (hr-  0. 
The  summer  muscles  were 
stored in potassium-free Ringer 
solution at 5°C for about 20 hr. 
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FIGURE 9.  The per cent inhibitions  of the K-sensitive  sodium  efflux were  measured 
under conditions similar  to those in Fig.  8.  One set used 80 mM sodium solutions, the 
other  105 n~  sodium Ringer solutions. Each point is the average from two pairs except 
10  -7 M strophanthidin in 105 mM sodium solution which is the average of four pairs. 
for comparison are the same drugs' inhibition of cesium uptake. The drugs fall 
into the same relative order for inhibition of sodium effiux or cesium uptake. 
Table  VII  compares  the  inhibitions  of both  assays  by  10  -6  and  10  -7  M 
strophanthidin  in  25  m_M  cesium  Ringer  solution.  Each  experimental  point 
was  the  average of two  experiments.  As was seen  in  the dose-activity curve A.  L.  AB~,LES  Structure-Activity Relationships of Cardiotonic Steroids  279 
for  strophanthidin  the  sensitivity  curve  for  sodium  effiux  inhibition  was 
steeper  than  that  for  cesium  uptake.  The  higher  concentration,  10  -6  ra, 
inhibited  sodium  efflux  more  than  cesium  uptake  while  10  -7  M  inhibited 
the effiux less than  the uptake. 
TABLE  VI 
COMPARISON  BETWEEN  THE  ABILITY 
OF VARIOUS  DRUGS  TO  INHIBIT SODIU]V[ 
EFFLUX  AND  CESIUM  UPTAKE 
Drug  Concentration 
Per cent inhibition 
Sodium efl]ux  (k~ium uptake 
Solution A 2.5 mM K  Solution E 2.5 mu 
M 
Cymarin  10  -6 
Strophanthidin  10  -6 
Periplogenin  10  -e 
100%  of K* stimulated (21%  984-2% 
of K-free rate) 
100%  of K  stimulated  854-5% 
34% of K  stimulated  294-1% 
Solution I  25 mu C_~  Solution E  2.5 rau Cs 
Cymarin  10  -7  58% of Cs stimulated  724-5% 
Strophanthidin  10  -7  39% of Cs stimulated  364-4% 
Periplogenin  10  -7  35% of Cs stimulated  (14-5%) 
* This drug inhibited all the potassium-stimulated rate and reduced the efllux to a  rate 21% 
below the rate into the potassium-free solution without drug. 
TABLE  VII 
INHIBITION  OF  CESIUM UPTAKE AND  SODIUM  EFFLUX 
IN  25  mM  CESIUM RINGER  SOLUTION 
Strophanthidin  Cesium uptake 
Per cent inhibition 
Sodium ¢flhm 
M 
10-6 
10-7 
84  100 of Cs stimulated, 22 of 
Cs-free 
60  39 
Effect of Increasing External  Potassium Concentration 
The inhibition of sodium efflux at three outside potassium concentrations was 
measured to determine whether potassium ion competes with the drug for the 
enzyme site. Fig.  10 compares the rates of sodium efflux, not corrected for the 
potassium-free efflux rates, in the various potassium Ringer solutions. One can 
see that at low potassium concentrations,  10  -5 and  10  -e  M strophanthidin  re- 
duced  the  sodium  efflux  to rates lower than  those  found  in  potassium-free ,',80  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  54  "  I969 
solutions. The lowest concentration tested,  l0  -s M, is not shown as it was not 
significantly different from the  control. The  other  concentrations show in- 
hibition at all potassium concentrations. Although some interaction was ob- 
served the results do not indicate competitive inhibition. The presence of a 
large potassium-free sodium effux and the fact that high concentrations of the 
drug can inhibit some of this effux, make the mechanism of transport more 
difficult to interpret. 
i  i  i  'i  J 
2.0 
~  1.6 
"~  1.2 
: 0.8 I/r  
=  0.4 
l  I  I  !  I  I 
2  4  6  8  I0  IZ 
mM  Potossium in Ringer 
FIGURe. 10.  Total sodium efflux was  measured  into potassium Ringer solutions with 
strophanthidin. The potassium-free rate is from 68 muscles while the other drug-treated 
rates are averages from 2 pairs. The control curve is an average of 16 pairs for 2.5 mM K, 
10 for 7.5 mM K, and 8 for 12 mM K  solutions. 
DISCUSSION 
Several slightly different cardiac drugs were used in these experiments in the 
hope that a knowledge of the structural requirements for drug activity might 
help to identify the nature of the drug-sensitive site on the membrane. This 
work examined several structural modifications of the drugs with respect to 
inhibition of ion transport in frog muscle. The trans-A/B form, uzarigenin, 
showed reduced activity compared with  the cis-A/B isomer,  digitoxigenin; 
the doses for 50o-/0 inhibition being 6.3  X  10  -6 M for uzarigenin and  1.6  X 
10  -6 u  for digitoxigenin. The lethal dosage in  cats for uzarigenin is  about 
twice that needed for digitoxigenin (Tamm,  1963). Kupchan and coworkers 
(1967)  compared  several  cardiac  steroids  for  their  cytotoxic  activity  and 
ATPase inhibition. In both assays activity of the drug was reduced with the 
change  from cis-A/B to trans-A/B. In frog muscle the  bufadienolide, telo- 
cinobufagin, was a  more potent inhibitor of transport than the similar car- 
denolide, periplogenin. Telocinobufagin was also found to be four times more 
potent for inhibiting transport in red blood cells than periplogenin (Kahn, 
1957).  Another bufagin,  hellebrigenin,  has  been  found  to  be  more  active 
against a  sodium-potassium ATPase than its  cardenolide isomer, strophan- 
thidin  (Ruoho et al.,  1968). However, compounds with saturated lactones A.  L.  AB~.tass  Structure-Activity  Relationships of Cardiotonic Steroids  28z 
were always less potent inhibitors of transport than their corresponding glyco- 
sides with unsaturated lactones and often less potent than the free genins of 
the same compounds (Kahn,  1957). 
Another variation examined was the C-19 methyl group compared with the 
C-19 aldehyde or hydroxymethyl groups. The C-19 aldehyde group resulted 
in a more potent compound than one with a C-19 methyl group as seen in the 
comparison of activity of strophanthidin and periplogenin. The same relation- 
ship was found for lethal dosages in cats (Chen,  1963; Tamm, 1963). A C-19 
hydroxymethyl group as on ouabain results in a more active compound than 
one with the methyl group. 
The importance of the 5-~-hydroxyl group and of the glycosidic sugars was 
examined. The 5-~-hydroxyl groups in strophanthidin, cymarin, periplogenin, 
and telocinobufagin result in increased potency for these drugs (Chen,  1963). 
Although 11-a-hydroxyl groups can give increased activity to the compound, 
the lack of oxygen-containing groups at C-19 and C-5 in sarmentogenin results 
in  a  weaker  compound. In the cardenolides the monosides are usually the 
most  active  (Tamm,  1963;  Chen,  1963).  Cymarin  and  ouabain  show 
this characteristic when cymarin is compared with strophanthidin. The pres- 
ence of the cymarose  gives  cymarin  increased  activity  especially  at  lower 
concentrations. Cymarin behaves much like ouabain which also is a monoside 
with rhamnose. Muscles treated with the glycosides, ouabain and cymarin, re- 
mained inhibited longer than the ones treated with the free genin, strophanthi- 
din, when they were resuspended in drug-free control solutions. A  comparison 
of the inhibition of sodium efflux by strophanthidin, cymarin, and periplo- 
genin with their inhibition of cesium uptake revealed no large differences in 
their relative activities in both assays. 
The results of the structural comparisons show the same structure-activity 
relationships which have been found in other systems such as red blood cell 
sodium-potassium transport. The most important area of the drug appears to 
be the unsaturated lactone and its E-link to C-17 of the D  ring of the steroid. 
Sugars at the C-3  position also increase the toxicity of the drugs but other 
changes, especially at C-19, are not as important. 
Although the concentrations of the drugs were measured in solutions  of 10  -6- 
10  -5 M before an experiment, no attempt was made to devise a  system for 
determining lower concentrations of the drugs, or to measure the concentration 
remaining in the solution after an experiment. Such measurements of the drug 
concentrations after an experiment might indicate that one reason for lower 
activitiy of a drug was that this drug was less well-absorbed by the muscle than 
the other drugs. Also, from the concentration of drug taken up by the muscle 
one  might  estimate  how  many  active  or  drug-sensitive sites  were  on  the 
muscle. However,  since the whole sartorius muscle was used rather  than a 
single fibril and because the extraceUular space of the muscle is large, 220-/0, 282  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  54  "  1969 
the estimate would not be very reliable. There also appears to be a  certain 
amount of unspecific binding of these drugs which would increase the error in 
any estimate of the number of drug-sensitive sites (Kupchan et al.,  1967). 
The early work by Glynn (1957) implied that scillaren A inhibition could be 
removed by increasing the potassium concentration. More recent experiments 
have shown that potassium does not compete with the drugs for sites. In fact, 
the amount of inhibition obtained depends on both the external potassium 
concentration  and  the  internal  and  external  sodium  concentrations  with 
external sodium ion increasing the observed inhibition by the drugs (Whittam 
and Ager,  1962;  Repke and  Portius,  1963;  Kinsolving,  Post,  and  Beaver, 
1963;  Schatzmann,  1963, 1965; Auditore,  1964, 1965; Baker and Connelly, 
1966). 
Matsui  and  Schwartz  (1966)  have  examined  the  competition  between 
potassium  ions  and  the  drugs  on  a  cardiac  sodium-potassium-dependent 
ATPase. They found that the interaction was noncompetitive  and depended on 
the sodium to potassium ratio in the solution. At a constant sodium concen- 
tration, the per cent inhibition of the ATPase by ouabain decreased with in- 
creasing potassium concentration while conversely, at a  constant potassium 
concentration the per cent inhibition increased with increasing sodium con- 
centration.  The  resulting kinetics were difficult to  determine because the 
sodium and potassium ions are competitive inhibitors of their respective ac- 
tivating sites.  In their experiments when the ratio of sodium to potassium in 
the medium was kept constant at l0 to 1 the double reciprocal plots, rate-' vs. 
[K] -1,  became linear and  indicated noncompetitive inhibition.  Matsui and 
Schwartz  concluded  that  the  ouabain-binding site  was  different from the 
potassium site. 
In these experiments the interaction between the drugs and potassium ion 
with respect to sodium efflux indicated that potassium ion could not prevent 
completely inhibition by strophanthidin. The same situation was true for in- 
hibition of cesium uptake when increased cesium concentration did not com- 
pletely remove strophanthidin inhibition. This indicated that the drugs were 
not truly competitive with potassium ion for a site on the transport enzyme. 
Since there is some sort of interaction one might suppose that the attachment 
of potassium ion or the drug to the enzyme changes the affinity of the enzyme 
toward the other. 
SUMMARY 
These studies indicate that the same structural details of the cardiac drugs, as 
are required to  inhibit  sodium-potassium-stimulated ATPase in  cell  mem- 
branes, and to cause heart fibrillation and death in cats and other animals, are 
important for their ability to inhibit sodium-potassium transport across cell 
membranes.  The comparison of  several  cardiac drugs  with different  sub- A.  L.  ABELES  Structure-Activity Relationships of Cardiotonic Steroids  283 
stituents  on the basic  steroid  showed that  the cis-A/B  configuration  of  the 
drug  was  a  more  active  inhibitor  of transport  than  the  trans-configuration,  a 
bufadienolide was more active than  the similar cardenolide,  the presence of a 
C-19  aldehyde  or hydroxymethyl  group  resulted  in a  more  active compound 
than  the presence of a  C-19 methyl group,  a  5-3-hydroxyl group resulted  in a 
more  active compound  than  one with  a  5-3-hydrogen,  and  monosides  of the 
cardenolides  were more active than  the free genins.  The  most important  area 
of the drug is the unsaturated  lactone and its/3-1ink to C- 17. These drugs act on 
the outside of the membrane  but not at the potassium site since potassium and 
the other ions do not show true competition with the drugs. The  attachment  of 
the  drugs  to  the  membrane  seems  to  be  slowly reversible  in  the  case  of the 
genins and very slowly or not at all reversible in the case of the glycosides. 
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